Zobrazeno 1 - 10
of 1 197
pro vyhledávání: '"Blood Glucose"'
Autor:
Qianqian Liu, Yun Liu, Feiye Zhou, Yuqing Zhang, Qin Zhu, Kecheng Zhu, Xiao Wang, Shushu Wang, Linlin Zhang, Hongju Tang, Libin Zhou, Xueying Ji
Publikováno v:
Metabolism. 98:62-75
Background Metformin has been widely used to alleviate hyperglycemia in patients with type 2 diabetes mainly via suppressing hepatic gluconeogenesis. However, the underlying mechanism remains incompletely clear. Here, we aimed to explore the role of
Publikováno v:
Metabolism. 97:25-31
An increasing number of women present pregnant having undergone bariatric surgery, a popular treatment for sustainable weight loss. The aim of the study was to investigate the effect, if any, of bariatric surgery on maternal and neonatal insulin resi
Autor:
Trenton T. Ross, Karyn L. Hamilton, Melissa A. Linden, Matthew Gorgoglione, William P. Esler, Benjamin F. Miller, Barry Braun, David A. Beebe
Publikováno v:
Metabolism. 97:68-80
Purpose Exercise is recommended in addition to pharmacotherapies for the management of type 2 diabetes, but metformin and exercise training may have non-additive or even inhibitory effects on exercise-induced improvements in glycemic control and exer
Autor:
Cecilie Fau Brinkløv, Kristian Karstoft, Bente Klarlund Pedersen, Fabiana Braga Benatti, David W. Dunstan, Nanna Skytt Pilmark, Mette Y. Johansen, Naja Z. Jespersen, Mathias Ried-Larsen, Ida Kær Thorsen
Publikováno v:
Metabolism. 96:1-7
Objective The primary objective was to test the hypothesis that increased frequency of interruptions in prolonged sitting reduces postprandial glycemia independent of energy intake and expenditure. Materials/Methods Healthy, sedentary, centrally obes
Autor:
Jing Ma, Adrian Vella, Chiara Dalla Man, Claudio Cobelli, Meera Shah, Robert A. Rizza, Marcello C. Laurenti
Publikováno v:
Metabolism. 93:10-17
Glucagon-Like Peptide-1 (GLP-1) is an insulin secretagogue which is elevated after Roux-en-Y Gastric Bypass (RYGB). However, its contribution to glucose metabolism after RYGB remains uncertain. Aims We tested the hypothesis that GLP-1 lowers postpran
Autor:
Christian S. Göbl, Wolfgang Eppel, Peter Klimek, Sabina Baumgartner-Parzer, Michael Leutner, Peter Husslein, Latife Bozkurt, Alexandra Kautzky-Willer, Stefan Thurner, Giovanni Pacini, Jürgen Harreiter
Publikováno v:
Metabolism. 91:10-17
The influential role of incretin hormones on glucose metabolism in patients with a history of Roux-en-Y gastric bypass (RYGB) has been investigated thoroughly, but there has been little examination of the effect of incretins and ectopic lipids on alt
Publikováno v:
Metabolism
Diabetes, one of the most prevalent chronic diseases in the world, is strongly associated with a poor prognosis in COVID-19. Scrupulous blood sugar management is crucial, since the worse outcomes are closely associated with higher blood sugar levels
Autor:
Chung-Yi Tseng, Jeffrey M. Karp, Christos S. Mantzoros, Yuhan Lee, Yangshuo Hu, Ali Tavakkoli, Margery A. Connelly, Tammy Lo
Publikováno v:
Metabolism
INTRODUCTION: Roux-en-Y gastric bypass surgery (RYGB) has been shown to be the gold standard treatment for obesity associated type-2-diabetes (T2D), however many T2D patients do not qualify or are reluctant to proceed with surgery due to its potentia
Autor:
Li Yang, Yu Hu, Tianshu Zeng, Ying Xu, Qin Li, An Pan, Wen Kong, Jiaoyue Zhang, Li Li, Lulu Chen, Hanyu Wang
Publikováno v:
Metabolism
Autor:
Sung-Il Cho, Yeon Young Cho
Publikováno v:
Metabolism. 85:14-22
Aims We explored the risks associated with metformin plus sulfonylurea (MET + SU) or MET plus a dipeptidyl peptidase-4 inhibitor (MET + DPP4i) for hypoglycemia, cardiovascular disease (CVD) events and all-cause mortality in type 2 diabetes (T2D) pati